Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 7/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.38 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL2153712 | 0.98 | TSHR (0.48) | TSHRALDH1A1TDP1HTTAR | |
| Ethylene SCHEMBL28248107 | 0.96 | TSHR (0.46) | TSHRALDH1A1TDP1HTTAR | |
| SCHEMBL2153618 | 0.85 | AR (0.45) | TSHRALDH1A1TDP1ARSLC22A12 | |
| SCHEMBL25668410 | 0.83 | AR (0.45) | TSHRALDH1A1HTTARSLC22A12 | |
| SCHEMBL30619339 | 0.82 | TSHR (0.46) | TSHRALDH1A1TDP1HTTAR | |
| SCHEMBL30539490 | 0.82 | TSHR (0.46) | TSHRALDH1A1HTTARCA2 | |
| SCHEMBL29852135 | 0.82 | AR (0.47) | TSHRALDH1A1HTTARSLC22A12 | |
| SCHEMBL151808 | 0.82 | TSHR (0.46) | TSHRALDH1A1HTTARCA2 | |
| SCHEMBL10471530 | 0.82 | TSHR (0.46) | TSHRALDH1A1HTTARCA2 | |
| SCHEMBL9034853 | 0.82 | TSHR (0.46) | TSHRALDH1A1TDP1HTTAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100335174-C | Method of preparing catalyst camied by composite oxides and application | UNIV WUHAN (CN) | 2007-09-05 | — | — | CN | claimed |
| CN-1660499-A | Method of preparing catalyst camied by composite oxides and application | UNIV WUHAN (CN) | 2005-08-31 | — | — | CN | claimed |
| CN-116535409-B | Pyrrolo-pyrrole-dione sulfonate compound and preparation method and application thereof | 华东理工大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20240239797-A1 | AKT1 MODULATORS | ALTEROME THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
| US-12030904-B2 | Phospholipid compounds and uses thereof | GILEAD SCIENCES, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030904-B2 | Phospholipid compounds and uses thereof | GILEAD SCIENCES, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12035618-B2 | Electroluminescent devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240224783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240218027-A1 | NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2024-07-04 | — | — | US | disclosed |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC | 2024-06-27 | — | — | US | disclosed |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC | 2024-06-27 | — | — | US | disclosed |
| WO-2005070407-A1 | METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-08-04 | — | — | WO | disclosed |
| EP-0985649-B1 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-20040152736-A1 | Thrombin receptor antagonists | TOPROL ACQUISITION LLC | 2004-08-05 | — | — | US | disclosed |
| US-6462248-B1 | THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS | TORAY INDUSTRIES, INC. (JP) | 2002-10-08 | — | — | US | disclosed |
| EP-0985649-A2 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0556156-B1 | Process for the preparation of 2-hydroxy-4,6-diaryl-1,3,5-triazine | CIBA GEIGY AG (CH) | 1996-09-25 | — | — | EP | disclosed |
| US-5288868-A | Intermediates in synthesis of ultraviolet light absorbers | CIBA-GEIGY CORPORATION (US) | 1994-02-22 | — | — | US | disclosed |
| EP-0580231-A1 | Process for the preparation of 4-tert-butylbenzaldehyde | IMI (TAMI) INSTITUTE FOR RESEARCH & DEVELOPMENT LTD. (IL) | 1994-01-26 | — | — | EP | disclosed |
| EP-0556156-A1 | Process for the preparation of 2-hydroxy-4,6-diaryl-1,3,5-triazine | CIBA-GEIGY AG (CH) | 1993-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239797-A1 | AKT1 MODULATORS | AKT1S1, AKT1, AKT2 | TSHR 3990/4885ALDH1A1 4692/4885TDP1 1721/4885 |
| US-12035618-B2 | Electroluminescent devices | ELAVL1, ELAVL3, JUND | TSHR 4120/4885ALDH1A1 1948/4885TDP1 186/4885 |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | PIK3CA, PIK3CG, PIK3CD | TSHR 4595/4885ALDH1A1 2457/4885TDP1 1022/4885 |
| US-12030904-B2 | Phospholipid compounds and uses thereof | PHOSPHO1, SGMS2, SGMS1 | TSHR 4567/4885ALDH1A1 3639/4885TDP1 2380/4885 |
| US-20040152736-A1 | Thrombin receptor antagonists | CNR1, TBXA2R, CNR2 | TSHR 97/4885ALDH1A1 3033/4885TDP1 1963/4885 |
| US-20240218027-A1 | NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | SLC35B2, SLC29A2, PNP | TSHR 2785/4885ALDH1A1 2777/4885TDP1 835/4885 |
| US-20240224783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | TSHR 2736/4885ALDH1A1 149/4885TDP1 3894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.